TABLE 1.
Anthropometrics and plasma analyte concentrations of women with obesity1
| Parameters | |
|---|---|
| Age, years | 38.0 ± 8.6 (21–51) |
| Weight, kg | 99.8 ± 22.1 (70.0–146) |
| BMI, kg/m2 | 36.8 ± 6.10 (30.0–51.4) |
| Waist circumference, cm | 102 ± 12.7 (82.0–134) |
| BP, systolic, mmHg | 128 ± 14.2 (98–155) |
| BP, diastolic, mmHg | 82.5 ± 9.90 (63–99) |
| Creatinine, μmol/L | 68.0 ± 8.90 (48–89) |
| AST, U/L | 17.1 ± 4.73 (11–29) |
| ALT, U/L | 17.1 ± 7.10 (10–37) |
| Cholesterol, mmol/L | 4.60 ± 0.70 (3.1–6.3) |
| HDL cholesterol, mmol/L | 1.50 ± 0.50 (1.0–3.1) |
| LDL cholesterol, mmol/L | 2.53 ± 0.80 (0.8–4.4) |
| TG, mmol/L | 1.30 ± 0.41 (0.5–1.9) |
| CRP, mmol/L | 7.60 ± 6.20 (1–26) |
| HbA1c, % | 5.41 ± 0.30 (4.8–6.3) |
| Compliance,2 flaxseed-oil phase, % | 96.7 ± 4.1 (86.1–100) |
| Compliance,2 fish-oil phase, % | 97.8 ± 2.2 (93.2–100) |
1
Values are reported as means ± SDs (ranges) from 21 (flaxseed-oil phase) or 22 (fish-oil phase) participants. ALT, alanine aminotransferase; AST, aspartate aminotransferase; BP, blood pressure; CRP, C-reactive protein; HbA1c, glycated hemoglobin; TG, triglyceride.
2
Calculated from self-reported doses missed.